122 related articles for article (PubMed ID: 24009027)
1. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
Lip GYH; Lane DA; Buller H; Apostolakis S
Chest; 2013 Dec; 144(6):1839-1847. PubMed ID: 24009027
[TBL] [Abstract][Full Text] [Related]
2. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.
Chen N; Brooks MM; Hernandez I
JAMA Netw Open; 2020 Feb; 3(2):e1921357. PubMed ID: 32074287
[TBL] [Abstract][Full Text] [Related]
3. Practice Patterns and Outcomes Associated With Use of Anticoagulation Among Patients With Atrial Fibrillation During Sepsis.
Walkey AJ; Quinn EK; Winter MR; McManus DD; Benjamin EJ
JAMA Cardiol; 2016 Sep; 1(6):682-90. PubMed ID: 27487456
[TBL] [Abstract][Full Text] [Related]
4. Performance of multilabel machine learning models and risk stratification schemas for predicting stroke and bleeding risk in patients with non-valvular atrial fibrillation.
Lu J; Hutchens R; Hung J; Bennamoun M; McQuillan B; Briffa T; Sohel F; Murray K; Stewart J; Chow B; Sanfilippo F; Dwivedi G
Comput Biol Med; 2022 Nov; 150():106126. PubMed ID: 36206696
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago.
Palareti G; Antonucci E; Migliaccio L; Erba N; Marongiu F; Pengo V; Poli D; Testa S; Tosetto A; Tripodi A; Moia M;
Intern Emerg Med; 2017 Dec; 12(8):1109-1119. PubMed ID: 28501909
[TBL] [Abstract][Full Text] [Related]
6. Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation.
Bernardini A; Bindini L; Antonucci E; Berteotti M; Giusti B; Testa S; Palareti G; Poli D; Frasconi P; Marcucci R
Int J Cardiol; 2024 Jul; 407():132088. PubMed ID: 38657869
[TBL] [Abstract][Full Text] [Related]
7. Optimising prediction of mortality, stroke, and major bleeding for patients with atrial fibrillation: validation of the GARFIELD-AF tool in UK primary care electronic records.
Apenteng PN; Prieto-Merino D; Hee SW; Lobban TC; Caleyachetty R; Fitzmaurice DA
Br J Gen Pract; 2023 Nov; 73(736):e816-e824. PubMed ID: 37845083
[TBL] [Abstract][Full Text] [Related]
8. Stroke and bleeding risk in atrial fibrillation.
Senoo K; Lane D; Lip GY
Korean Circ J; 2014 Sep; 44(5):281-90. PubMed ID: 25278980
[TBL] [Abstract][Full Text] [Related]
9. Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
Hobbs FD; Roalfe AK; Lip GY; Fletcher K; Fitzmaurice DA; Mant J;
BMJ; 2011 Jun; 342():d3653. PubMed ID: 21700651
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Disease: Anticoagulation Therapy for Atrial Fibrillation.
Criswell W; Gauer RL
FP Essent; 2024 Jan; 536():14-21. PubMed ID: 38227451
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences.
Goel N; Jain D; Haddad DB; Shanbhogue D
J Stroke; 2020 Sep; 22(3):306-316. PubMed ID: 33053946
[TBL] [Abstract][Full Text] [Related]
12. [Antithrombotiques oraux et pronostic après un an des patients atteints de fibrillation auriculaire dans un milieu à ressources limitées].
Dzudie A; Kwawa I; Magha I; Mouliom S; Magnerou AM; Massi DG; Barche B; Ndjebet J; Fotsing MM; Lade V; Djomou A; Ndom MS; Abanda MH; Majunda Ekaney DS; Ongeh NJ; Ebasone PV; Kamdem F; Mbatchou BH; Njankouo YM
Ann Cardiol Angeiol (Paris); 2023 Oct; 72(4):101616. PubMed ID: 37331159
[TBL] [Abstract][Full Text] [Related]
13. New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants.
Ma F; Chen J; Chang S; Huang N; Zhang W; Dai H; Zheng Q; Li R; Lin X; Liu Y; Du X; Su J; Huang X; Chen X; Hu W; Liu X; Zhang Y; Gu P; Zhang J
Blood Coagul Fibrinolysis; 2023 Dec; 34(8):530-537. PubMed ID: 37942745
[TBL] [Abstract][Full Text] [Related]
14. Clinician-Created Video Education for Patients With AF: A Randomized Clinical Trial.
McIntyre D; Kovoor JG; Chow CK; Quintans D; Marschner S; Thomas S; Kovoor P; Thiagalingam A
JAMA Netw Open; 2023 Dec; 6(12):e2345308. PubMed ID: 38064218
[TBL] [Abstract][Full Text] [Related]
15. Turkish Real Life Atrial Fibrillation in Clinical Practice: TRAFFIC Study.
Karabay CY; Taşolar H; Ülgen Kunak A; Çap M; Astarcıoğlu MA; Şen T; Kaplan M; Coşgun MS; Vatansever Ağca F; Arslan U; Açıksarı G; Er F; Mert KU; Özdoğan Ö; Çalışkan S; Akşit E; Yılmaz AS; Aksakal E; Şimşek Z; Efe SÇ; Aktüre G; Böyük F; Başaran Ö; Ballı M; Aslan AO; Babur Güler G; Batgerel U; Özkalaycı F; Kaya BC; Kanar BG; Karakayalı M; Erdoğan E; İş G; Kalkan S; Demirel S; Aksu U; Güray Ü; Baş HA; Gök M; Yılmaz MF; Şimşek B; Kolak Z; Öz M; Uluköksal U; Kuloğlu HE; Çabuk G; Köksal F; Nizam AC; Çoldur R; Şaylık F; Tanboğa İH
Anatol J Cardiol; 2024 Jan; 28(2):87-93. PubMed ID: 38168008
[TBL] [Abstract][Full Text] [Related]
16. Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis.
Pasea L; Chung SC; Pujades-Rodriguez M; Shah AD; Alvarez-Madrazo S; Allan V; Teo JT; Bean D; Sofat R; Dobson R; Banerjee A; Patel RS; Timmis A; Denaxas S; Hemingway H
BMC Med; 2019 Nov; 17(1):206. PubMed ID: 31744503
[TBL] [Abstract][Full Text] [Related]
17. Differences in outcomes between oral anticoagulation "new starters" and "switchers" in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials.
Bai Y; Shantsila A; Lip GYH
J Arrhythm; 2019 Dec; 35(6):815-820. PubMed ID: 31844472
[TBL] [Abstract][Full Text] [Related]
18. Bleeding risk evaluation in cerebral cavernous malformation, the role of medications, and hemorrhagic factors: a case-control study.
Scerrati A; Mantovani G; Travaglini F; Bradaschia L; De Bonis P; Farneti M; Cavallo MA; Dones F; Flacco ME; Auricchio AM; Benato A; Albanese A; Sturiale CL
Neurosurg Focus; 2023 Oct; 55(4):E15. PubMed ID: 37778034
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors of a new cardio-embolic cerebral accident in non-valvular atrial fibrillation treated with acenocoumarol].
Vázquez Muñoz E; Gómez Cerezo J; Fernández Pavón A
Aten Primaria; 2001 Jun; 28(1):46-9. PubMed ID: 11412577
[TBL] [Abstract][Full Text] [Related]
20. Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation.
Gue Y; Bloomfield D; Freedholm D; Lip GYH
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
